Net Loss per Share Attributable to Common Stockholders (Tables)

6 Months Ended

Jun. 30, 2025

Schedule of Basic and Diluted Net Loss per Share

The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders which excludes shares which are legally outstanding, but subject to repurchase by the Company (in thousands, except share and per share amounts):


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Numerator
Net loss attributable to common stockholders	$	(15,173)	$	(15,326)	$	(29,621)	$	(29,075)
Denominator
Weighted-average common stock outstanding	40,429,655		38,943,110		40,193,469		38,789,609
Less: weighted-average common shares subject to repurchase	—		(44)		—		(61)
Weighted-average common shares used to compute basic and diluted net loss per share	40,429,655		38,943,066		40,193,469		38,789,548
Net loss per share attributable to common stockholders, basic and diluted	$	(0.38)	$	(0.39)	$	(0.74)	$	(0.75)

Schedule of Potentially Dilutive Securities Outstanding

The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an antidilutive impact due to the Company’s net loss, in common stock equivalent shares:


	As of June 30
	2025	2024
Options to purchase common stock	3,657,135	3,766,402
Unvested restricted stock units	4,412,948	3,197,736
Shares committed under employee stock purchase plan	43,907	51,487
Unvested early exercised common stock options	—	23
Total	8,113,990	7,015,648

Pulmonx Corp 10-Q